← 產業報告目錄
Rare Gastrointestinal Diseases Treatment Market Size, Share & Trends Analysis Report By Treatment (Medications, Nutritional support), By End-User (Hospitals, Research Institutes, Others), By Region, And By Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-07頁數 179報告編號 INSIGHTACE-1a55fe3510
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Rare Gastrointestinal Diseases Treatment Market on a global scale was estimated at USD 1.29 Bn in 2022 and is anticipated to attain USD 1.68 Bn by 2031, with a projected CAGR of 3.1% between 2023 and 2031.
Rare Gastrointestinal Diseases Treatment encompasses gastrointestinal disorders are those that affect the gi (gastrointestinal tract) from the mouth to the anus. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is supported by surging appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Rare Gastrointestinal Diseases Treatment Market Snapshot
Chapter 4. Global Rare Gastrointestinal Diseases Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Treatment Type Estimates & Trend Analysis
5.1. By Treatment Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Treatment Type:
5.2.1. Medications
5.2.2. Nutritional Support
Chapter 6. Market Segmentation 2: By End User Estimates & Trend Analysis
6.1. By End User & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End User:
6.2.1. Hospitals
6.2.2. Research Institutes
6.2.3. Other End User Settings
Chapter 7. Rare Gastrointestinal Diseases Treatment Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) estimates and forecasts By Treatment Type, 2019-2031
7.1.2. North America Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
7.1.3. North America Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By Treatment Type, 2019-2031
7.2.2. Europe Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By End User, 2019-2031
7.2.3. Europe Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By Treatment Type, 2019-2031
7.3.2. Asia Pacific Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By End User, 2019-2031
7.3.3. Asia Pacific Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By Treatment Type, (US$ Million) 2019-2031
7.4.2. Latin America Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
7.4.3. Latin America Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By Treatment Type, (US$ Million) 2019-2031
7.5.2. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
7.5.3. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market revenue (US$ Million) by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Bayer Pharmaceutical Corp
8.2.2. Teva Pharmaceutical
8.2.3. Novartis AG
8.2.4. Sanofi
8.2.5. Pfizer, Inc.
8.2.6. GlaxoSmithKline PLC
8.2.7. Eli Lilly and CO.
8.2.8. Johnson & Johnson
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們